Trial · NCT00546754
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Systolic Blood Pressure From Baseline to Week 6 | Losartan 50 mg/HCTZ 12.5 mg | -16.7 | Standard Deviation 14.70 | mm Hg | |
| Change in Systolic Blood Pressure From Baseline to Week 6 | Valsartan 80 mg/HCTZ 12.5 mg | -18.2 | Standard Deviation 13.84 | mm Hg | |
| Change in Diastolic Blood Pressure From Baseline to Week 6 | Losartan 50 mg/HCTZ 12.5 mg | -8.4 | Standard Deviation 9.35 | mm Hg | |
| Change in Diastolic Blood Pressure From Baseline to Week 6 | Valsartan 80 mg/HCTZ 12.5 mg | -9.1 | Standard Deviation 9.16 | mm Hg | |
| Number of Patients Achieving Target Blood Pressure at Week 6 | Losartan 50 mg/HCTZ 12.5 mg | Achieved Target Blood Pressure | 253 | Patients | |
| Number of Patients Achieving Target Blood Pressure at Week 6 | Valsartan 80 mg/HCTZ 12.5 mg | Achieved Target Blood Pressure | 241 | Patients | |
| Number of Patients Achieving Target Blood Pressure at Week 6 | Losartan 50 mg/HCTZ 12.5 mg | Did Not Achieve Target Blood Pressure | 140 | Patients | |
| Number of Patients Achieving Target Blood Pressure at Week 6 | Valsartan 80 mg/HCTZ 12.5 mg | Did Not Achieve Target Blood Pressure | 104 | Patients | |
| Change in Systolic Blood Pressure From Baseline to Week 12 | Losartan 50 mg/HCTZ 12.5 mg | -19.9 | Standard Deviation 13.79 | mm Hg | |
| Change in Systolic Blood Pressure From Baseline to Week 12 | Valsartan 80 mg/HCTZ 12.5 mg | -20.8 | Standard Deviation 13.61 | mm Hg | |
| Number of Patients Achieving Target Blood Pressure at Week 12 | Losartan 50 mg/HCTZ 12.5 mg | Achieved Target Blood Pressure | 278 | Patients | |
| Number of Patients Achieving Target Blood Pressure at Week 12 | Valsartan 80 mg/HCTZ 12.5 mg | Achieved Target Blood Pressure | 253 | Patients | |
| Number of Patients Achieving Target Blood Pressure at Week 12 | Losartan 50 mg/HCTZ 12.5 mg | Did Not Achieve Target Blood Pressure | 94 | Patients | |
| Number of Patients Achieving Target Blood Pressure at Week 12 | Valsartan 80 mg/HCTZ 12.5 mg | Did Not Achieve Target Blood Pressure | 79 | Patients | |
| Time to Achieve Target Blood Pressure | Losartan 50 mg/HCTZ 12.5 mg | 62.3 | Standard Deviation 1.44 | Days | |
| Time to Achieve Target Blood Pressure | Valsartan 80 mg/HCTZ 12.5 mg | 57.3 | Standard Deviation 1.24 | Days | |
| Change in Uric Acid From Baseline to Week 6 | Losartan 50 mg/HCTZ 12.5 mg | 0.3 | Standard Deviation 53.12 | umol/L | |
| Change in Uric Acid From Baseline to Week 6 | Valsartan 80 mg/HCTZ 12.5 mg | 21.7 | Standard Deviation 55.09 | umol/L | |
| Change in Diastolic Blood Pressure From Baseline to Week 12 | Losartan 50 mg/HCTZ 12.5 mg | -10.6 | Standard Deviation 9.28 | mm Hg | |
| Change in Diastolic Blood Pressure From Baseline to Week 12 | Valsartan 80 mg/HCTZ 12.5 mg | -10.5 | Standard Deviation 9.58 | mm Hg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00546754/results